Study tests gentler way to harvest cells for cancer transplant
NCT ID NCT05517213
Summary
This study compared two drug combinations used to collect a patient's own stem cells from their blood before a transplant for multiple myeloma. Researchers wanted to see if one method (using etoposide) was more effective and caused fewer side effects than the standard method (using cyclophosphamide). The goal was to find a better way to collect enough healthy cells so more patients could successfully proceed with their transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital 307
Beijing, Beijing Municipality, 100071, China
Conditions
Explore the condition pages connected to this study.